| Efficacy and safety of low-dose pioglitazone after primary coronary angioplasty with the use of bare metal stent in patients with acute myocardial infarction and with type 2 diabetes mellitus or impaired glucose tolerance. | |
| | |
MedLine Citation:
|
PMID: 17533517 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Thiazolidinediones (TZDs) have beneficial effects on markers of cardiovascular risk in patients with type 2 diabetes mellitus (DM). This study aimed to investigate the efficacy and safety of low-dose pioglitazone (15 mg per day) in patients with acute myocardial infarction (AMI) and type 2 DM or impaired glucose tolerance (IGT) treated with coronary angioplasty using bare metal stent (BMS). In 56 patients, pioglitazone was orally administered for 6 months after stenting (pioglitazone group). The incidence of in-stent restenosis (ISR) and left ventricular end-diastolic volume index (LVEDVI) at acute phase and 6 months after stenting in these patients were retrospectively compared with those in the other 37 patients (control group) treated without pioglitazone. No adverse events including death, emergency bypass surgery, and reinfarction, occurred in any patients in the hospital. There was no congestive heart failure (CHF) during a follow-up period in the pioglitazone group. At 6 months after stenting, the overall angiographic ISR rate was significantly lower in the pioglitazone group than in the control group (28.6% vs 48.6%, P = 0.049). In patients with hemoglobin A1c (HbA1c) <7.0% at follow-up, the ISR rate was also significantly lower in the pioglitazone group than in controls (21.3% vs 44.8%, P = 0.03). Delta-LVEDVI (defined as follow-up LVEDVI minus acute LVEDVI) was similar between the pioglitazone group and control group (0.13 vs 5.16 ml/m(2), P = 0.482). Low-dose pioglitazone seems to have a potential to reduce ISR and does not adversely affect LV remodeling after AMI treated with coronary angioplasty using BMS in patients with type 2 DM or IGT. |
| | |
Authors:
|
Jin Yokoyama; Naoyuki Sutoh; Takumi Higuma; Daisuke Horiuchi; Chisato Katoh; Takashi Yokota; Takashi Echizen; Shingo Sasaki; Hiroyuki Hanada; Tomohiro Osanai; Ken Okumura |
Related Documents
:
|
14969627 - Intravascular ultrasound study of effects of overlapping sirolimus-eluting stents. 8993807 - Analysis of reproducibility of reference lumen quantitation with intravascular ultrasou... 21045717 - Optical coherence tomography in st-elevation myocardial infarction treated with novel d... 18296847 - Inflammation and delayed endothelization with overlapping drug-eluting stents in a porc... 12509477 - Heart failure -- a challenge to our current concepts of excitation-contraction coupling. 16932087 - Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrilla... |
Publication Detail:
|
Type: Journal Article Date: 2007-05-21 |
Journal Detail:
|
Title: Heart and vessels Volume: 22 ISSN: 0910-8327 ISO Abbreviation: Heart Vessels Publication Date: 2007 May |
Date Detail:
|
Created Date: 2007-05-29 Completed Date: 2007-10-18 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8511258 Medline TA: Heart Vessels Country: Japan |
Other Details:
|
Languages: eng Pagination: 146-51 Citation Subset: IM |
Affiliation:
|
Department of Cardiology, Hirosaki University School of Medicine, Zaifu-cho 5, Hirosaki, 036-8562, Japan. yokoyama@cardiologist.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary* Chi-Square Distribution Coronary Angiography Diabetes Mellitus, Type 2 / drug therapy* Female Glucose Intolerance / drug therapy* Humans Hypoglycemic Agents / administration & dosage* Male Middle Aged Myocardial Infarction / complications, therapy* Retrospective Studies Stents* Thiazolidinediones / administration & dosage* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Hypoglycemic Agents; 0/Thiazolidinediones; 111025-46-8/pioglitazone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Postprocedural resistance of the target lesion is a strong predictor of subsequent revascularization...
Next Document: Impact of post-dilatation with a focal expanding balloon for optimization of intracoronary stenting.